These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 10853973)

  • 21. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
    Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
    Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
    Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
    Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
    Melby PC; Yang YZ; Cheng J; Zhao W
    Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum.
    Nigro L; Cacopardo B; Preiser W; Braner J; Cinatl J; Palermo F; Russo R; Doerr HW; Nunnari A
    Am J Trop Med Hyg; 1999 Jan; 60(1):142-5. PubMed ID: 9988338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
    Tripathi P; Ray S; Sunder S; Dube A; Naik S
    Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.
    Murray HW; Hariprashad J; Coffman RL
    J Exp Med; 1997 Mar; 185(5):867-74. PubMed ID: 9120392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
    Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
    Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
    Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
    Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
    J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals.
    Kurtzhals JA; Kemp M; Poulsen LK; Hansen MB; Kharazmi A; Theander TG
    Scand J Immunol; 1995 Apr; 41(4):343-9. PubMed ID: 7899822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
    de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
    Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
    Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
    Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE; Ng W; Wilson CB; McMaster WR; Burchett SK
    J Clin Invest; 1990 Jun; 85(6):1914-24. PubMed ID: 2112157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.
    Sundar S; Reed SG; Sharma S; Mehrotra A; Murray HW
    Am J Trop Med Hyg; 1997 May; 56(5):522-5. PubMed ID: 9180602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.